Generic Name and Formulations:
Ciprofloxacin 6% (60mg/mL); otic susp; preservative-free.
Indications for OTIPRIO:
Bilateral otitis media with effusion undergoing tympanostomy tube placement. Acute otitis externa due to P. aeruginosa and S. aureus.
Adults and Children:
<6mos: not established. For intratympanic or otic administration only. ≥6mos: Otitis media: give as one 0.1mL (6mg) single dose into each affected ear, following suctioning of middle ear effusion. Otitis externa: give as one 0.2mL (12mg) single dose to the external ear canal of each affected ear.
Potential for microbial overgrowth (eg, bacteria, fungi); if infections occur, use alternatives. Pregnancy.
Nasopharyngitis, irritability, ear pruritus, headache, otitis media, ear discomfort.
Single-patient use vial—1mL
Clinical Pain Advisor Articles
- Virtual Reality May Effectively Reduce Sensory, Affective, and Cognitive Pain During Labor
- Suprazygomatic Sphenopalatine Ganglion Block May Quickly Relieve Status Migrainosus Pain
- Reducing Mortality After Overdose: Is Treatment for Opioid Use Disorder Effective?
- A Physician's Guide to Incorporating Patient Spirituality in Practice
- Low Literacy Self-Management Program for Chronic Pain May Be Effective
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Ketamine Infusions May Be Effective for Refractory Headache
- Physical, Psychosocial Activity May Be Protective Against Development of Chronic Pain in Older Adults
- The Challenge of Compassion in Modern Healthcare Settings
- Republican Opposition to Obamacare: What's Done, What's to Come
- Lowering Default Pill Counts in EMRs May Effectively Reduce Postoperative Opioid Prescription Numbers
- Steps Taken to Increase Use of Electronic Tools in Medicine
- Daily and Retrospective Pain Measurements Comparable in Hip Osteoarthritis